Cargando…
Correction for: Efficacy and safety of recombinant human follicle-stimulating hormone in patients undergoing in vitro fertilization-embryo transfer
Autores principales: | Hu, Linli, Zhang, Songying, Quan, Song, Lv, Jieqiang, Qian, Weiping, Huang, Yuanhua, Lu, Weiying, Sun, Yingpu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10333087/ https://www.ncbi.nlm.nih.gov/pubmed/37384564 http://dx.doi.org/10.18632/aging.204490 |
Ejemplares similares
-
Efficacy and safety of recombinant human follicle-stimulating hormone in patients undergoing in vitro fertilization-embryo transfer
por: Hu, Linli, et al.
Publicado: (2020) -
Comparison of corifollitropin alfa and daily recombinant follicle-stimulating hormone in poor responder patients undergoing in vitro fertilization cycles
por: Akarsu, Süleyman, et al.
Publicado: (2017) -
Editorial: Follicle-Stimulating Hormone: Fertility and Beyond
por: Simoni, Manuela, et al.
Publicado: (2019) -
Role of the proportion of dominant follicles in patients with polycystic ovary syndrome undergoing in vitro fertilization-embryo transfer
por: Lin, Hai-Yan, et al.
Publicado: (2019) -
Gonadotropin versus Follicle-Stimulating Hormone for Ovarian Response in Patients Undergoing in vitro Fertilization: A Retrospective Cohort Comparison
por: Ji, Zhisong, et al.
Publicado: (2019)